{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:48:02Z","timestamp":1788994082258,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.regpep.2006.06.004","type":"journal-article","created":{"date-parts":[[2006,8,18]],"date-time":"2006-08-18T07:13:23Z","timestamp":1155885203000},"page":"121-127","source":"Crossref","is-referenced-by-count":70,"title":["Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187"],"prefix":"10.1016","volume":"137","author":[{"given":"Bronislava R.","family":"Gedulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Jodka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2006.06.004_bib1","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2006.06.004_bib2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI114528","article-title":"Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment","volume":"85","author":"Ogawa","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.regpep.2006.06.004_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00060793-199708000-00006","article-title":"Amylin's physiology and its role in diabetes","volume":"4","author":"Young","year":"1997","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"10.1016\/j.regpep.2006.06.004_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.regpep.2006.06.004_bib5","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1210\/en.140.6.2924","article-title":"An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3","volume":"140","author":"Muff","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2006.06.004_bib6","first-page":"493","article-title":"High affinity amylin binding sites in rat brain","volume":"44","author":"Beaumont","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.regpep.2006.06.004_bib7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF00401833","article-title":"Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin","volume":"38","author":"Young","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2006.06.004_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s001250050646","article-title":"Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM","volume":"40","author":"Kong","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2006.06.004_bib9","doi-asserted-by":"crossref","first-page":"G946","DOI":"10.1152\/ajpgi.2000.278.6.G946","article-title":"Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition","volume":"278","author":"Samsom","year":"2000","journal-title":"Am J Physiol Gasterointest Liver Physiol"},{"key":"10.1016\/j.regpep.2006.06.004_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose\u2013response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.regpep.2006.06.004_bib11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2002-34790","article-title":"The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus","volume":"34","author":"Fineman","year":"2002","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.regpep.2006.06.004_bib12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/meta.2002.32022","article-title":"The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes","volume":"51","author":"Fineman","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.regpep.2006.06.004_bib13","first-page":"493","article-title":"High affinity amylin binding sites in rat brain","volume":"44","author":"Beaumont","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.regpep.2006.06.004_bib14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1139\/y95-144","article-title":"Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists","volume":"73","author":"Beaumont","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.regpep.2006.06.004_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(94)80563-6","article-title":"Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat \u2014 evidence for a metabolic role of endogenous amylin","volume":"343","author":"Young","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.regpep.2006.06.004_bib16","article-title":"Effect of amylin receptor antagonist, AC187, on labelled glucose absorption and oral glucose tolerance in corpulent LA\/N rats","volume":"vol. 40","author":"Gedulin","year":"1994"},{"key":"10.1016\/j.regpep.2006.06.004_bib17","first-page":"A244","article-title":"Endogenous amylin and gastric emptying in rats: comparison with GLP-1 and CCK-8","volume":"38","author":"Gedulin","year":"1995","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"10.1016\/j.regpep.2006.06.004_bib18","first-page":"238A","article-title":"Neutralizing antibody and the antagonist AC187 may inhibit glucagon secretion in rats","volume":"40","author":"Gedulin","year":"1997","journal-title":"Diabetes"},{"issue":"suppl 4","key":"10.1016\/j.regpep.2006.06.004_bib19","first-page":"S18","article-title":"Endogenous amylin inhibits glucagon secretion, as demonstrated by studies using neutralizing antibody and the antagonist AC187","volume":"14","author":"Gedulin","year":"1997","journal-title":"Diabet Med"},{"issue":"suppl 1","key":"10.1016\/j.regpep.2006.06.004_bib20","first-page":"A300","article-title":"Studies using neutralizing antibody and the antagonist AC187 reveal that endogenous amylin inhibits glucagon secretion","volume":"40","author":"Gedulin","year":"1997","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"10.1016\/j.regpep.2006.06.004_bib21","doi-asserted-by":"crossref","first-page":"I-101","DOI":"10.1161\/01.HYP.19.1_Suppl.I101","article-title":"Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA\/N-cp rats","volume":"19","author":"Huang","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.regpep.2006.06.004_bib22","article-title":"Effect of amylin to inhibit food intake in rats can be blocked with the selective amylin receptor antagonist, AC187","volume":"vol. 419","author":"Watkins","year":"1996"},{"key":"10.1016\/j.regpep.2006.06.004_bib23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1139\/y95-144","article-title":"Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists","volume":"73","author":"Beaumont","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.regpep.2006.06.004_bib24","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(92)90084-J","article-title":"8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats","volume":"84","author":"Young","year":"1992","journal-title":"Mol Cell Endocrinol"},{"issue":"suppl 1","key":"10.1016\/j.regpep.2006.06.004_bib25","first-page":"229A","article-title":"The selective amylin antagonist, AC187, enhances the insulin response during intravenous glucose tolerance tests in anesthetized rats","volume":"42","author":"Gedulin","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2006.06.004_bib26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diabetes.42.2.330","article-title":"Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets","volume":"42","author":"Wang","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2006.06.004_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF00408483","article-title":"Amylin tonally regulates arginine-stimulated insulin secretion in rats","volume":"37","author":"Bennet","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2006.06.004_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/dmrr.263","article-title":"Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity","volume":"18","author":"Mather","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.regpep.2006.06.004_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1006\/bbrc.1995.2658","article-title":"Lactate production from the rat hindlimb is increased after glucose administration and is suppressed by a selective amylin antagonist: evidence for action of endogenous amylin in skeletal muscle","volume":"216","author":"Vine","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"suppl 2","key":"10.1016\/j.regpep.2006.06.004_bib30","first-page":"55","article-title":"Effects of AC187, IAPP(8-37) and CGRP(8-37) on IAPP induced anorexia in rats","volume":"58","author":"Granqvist","year":"1997","journal-title":"Digestion"},{"key":"10.1016\/j.regpep.2006.06.004_bib31","first-page":"102.37","article-title":"Effects of AC187, IAPP 8-37, and CGRP 8-37 on IAPP-induced anorexia in rats","volume":"23","author":"Arnelo","year":"1997","journal-title":"Proc Neurosci Abstr"},{"key":"10.1016\/j.regpep.2006.06.004_bib32","doi-asserted-by":"crossref","first-page":"R568","DOI":"10.1152\/ajpregu.00213.2004","article-title":"Amylin receptor blockade stimulates food intake in rats","volume":"287","author":"Reidelberger","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.regpep.2006.06.004_bib33","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1210\/en.142.11.5035","article-title":"Inhibition of central amylin signaling increases food intake and body adiposity in rats","volume":"142","author":"Rushing","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2006.06.004_bib34","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1152\/ajpregu.00333.2003","article-title":"The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut\u2013brain axis","volume":"286","author":"Riediger","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.regpep.2006.06.004_bib35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1172\/JCI106297","article-title":"Studies of pancreatic alpha cell function in normal and diabetic subjects","volume":"49","author":"Unger","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1016\/j.regpep.2006.06.004_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJM197007162830301","article-title":"Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion","volume":"283","author":"M\u00fcller","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2006.06.004_bib37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0140-6736(92)90785-2","article-title":"Amylin concentrations and glucose control","volume":"339","author":"Koda","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.regpep.2006.06.004_bib38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0026-0495(99)90232-9","article-title":"The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus","volume":"48","author":"Nyholm","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.regpep.2006.06.004_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.26.1.1","article-title":"Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps","volume":"26","author":"Levetan","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2006.06.004_bib40","doi-asserted-by":"crossref","first-page":"E443","DOI":"10.1152\/ajpendo.2001.280.3.E443","article-title":"Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas","volume":"280","author":"Silvestre","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.regpep.2006.06.004_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.regpep.2006.06.004_bib42","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1139\/y95-146","article-title":"Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain","volume":"73","author":"Christopoulos","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.regpep.2006.06.004_bib43","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1440-1681.2000.03259.x","article-title":"Circumventricular organs: definition and role in the regulation of endocrine and autonomic function","volume":"27","author":"Ganong","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.regpep.2006.06.004_bib44","first-page":"110","article-title":"Accelerated gastric emptying in diabetic rodents: effect of insulin treatment and pancreas transplantation","volume":"123","author":"Nowak","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.regpep.2006.06.004_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s001250050654","article-title":"Accelerated gastric emptying of glucose in Zucker type 2 diabetic rats: role in postprandial hyperglycaemia","volume":"40","author":"Green","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2006.06.004_bib46","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/(SICI)1096-9136(199706)14:2+<S14::AID-DIA398>3.3.CO;2-H","article-title":"Role of amylin in nutrition intake: animal studies","volume":"14","author":"Young","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.regpep.2006.06.004_bib47","first-page":"26","article-title":"Area postrema (AP)-lesions block the regulation of gastric emptying by amylin","volume":"10","author":"Edwards","year":"1998","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.regpep.2006.06.004_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1389450053174596","article-title":"Pancreatic amylin as a centrally acting satiating hormone","volume":"6","author":"Lutz","year":"2005","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.regpep.2006.06.004_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1054-3589(05)52005-2","article-title":"Inhibition of food intake","volume":"52","author":"Young","year":"2005","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.regpep.2006.06.004_bib50","doi-asserted-by":"crossref","first-page":"R1833","DOI":"10.1152\/ajpregu.2001.281.6.R1833","article-title":"Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP","volume":"281","author":"Riediger","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.regpep.2006.06.004_bib51","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial","volume":"26","author":"Hollander","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2006.06.004_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2982.2002.00311.x","article-title":"Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus","volume":"14","author":"Vella","year":"2002","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.regpep.2006.06.004_bib53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s001250050949","article-title":"The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM","volume":"41","author":"Kong","year":"1998","journal-title":"Diabetologia"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011506000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011506000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T15:02:08Z","timestamp":1555772528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011506000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0167011506000954"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2006.06.004","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}